| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |